Literature DB >> 25918933

The role of curcumin as an inhibitor of oxidative stress caused by ischaemia re-perfusion injury in tetralogy of Fallot patients undergoing corrective surgery.

Rubiana Sukardi1, Sudigdo Sastroasmoro2, Nurjati C Siregar3, Mulyadi M Djer2, Fransciscus D Suyatna4, Mohammad Sadikin5, Nurhadi Ibrahim6, Sri E Rahayuningsih7, Arief B Witarto8.   

Abstract

BACKGROUND: Cardiopulmonary bypass during tetralogy of Fallot corrective surgery is associated with oxidative stress, and contributes to peri-operative problems. Curcumin has been known as a potent scavenger of reactive oxygen species, which enhances the activity of antioxidants and suppresses phosphorylation of transcription factors involved in inflamation and apoptosis.
OBJECTIVES: To evaluate the effects of curcumin as an antioxidant by evaluating the concentrations of malondialdehyde and glutathione, activity of nuclear factor-kappa B, c-Jun N-terminal kinase, caspase-3, and post-operative clinical outcomes.
METHODS: Tetralogy of Fallot patients for corrective surgery were randomised to receive curcumin (45 mg/day) or placebo orally for 14 days before surgery. Malondialdehyde and glutathione concentrations were evaluated during the pre-ischaemia, ischaemia, re-perfusion phases, and 6 hours after aortic clamping-off. Nuclear factor-kappa B, c-Jun N-terminal kinase, and caspase-3, taken from the infundibulum, were assessed during the pre-ischaemia, ischaemia, and re-perfusion phases. Haemodynamic parameters were monitored until day 5 after surgery.
RESULTS: In all the observation phases, malondialdehyde and glutathione concentrations were similar between groups. There was no significant difference in nuclear factor-kappa B activity between the groups for three observations; however, in the curcumin group, c-Jun N-terminal kinase significantly decreased from the pre-ischaemia to the re-perfusion phases, and caspase-3 expression was lower in the ischaemia phase. Patients in the curcumin group had lower temperature and better ventricular functions, but no significant differences were found in mechanical ventilation day or length of hospital stay in the two groups.
CONCLUSION: Cardioprotective effects of curcumin may include inhibition of the c-Jun N-terminal kinase pathway and caspase-3 in cardiomyocytes, particularly in the ischaemia phase.

Entities:  

Keywords:  Curcumin; apoptosis; ischaemia re-perfusion injury

Mesh:

Substances:

Year:  2015        PMID: 25918933     DOI: 10.1017/S1047951115000360

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  5 in total

Review 1.  Systemic Inflammation, Oxidative Stress and Cardiovascular Health in Children and Adolescents: A Systematic Review.

Authors:  Tjaša Hertiš Petek; Tadej Petek; Mirjam Močnik; Nataša Marčun Varda
Journal:  Antioxidants (Basel)       Date:  2022-04-30

Review 2.  The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases.

Authors:  Levi W Evans; Maheshi Athukorala; Kristina Martinez-Guryn; Bradley S Ferguson
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

Review 3.  Curcumin, Gut Microbiota, and Neuroprotection.

Authors:  Francesco Di Meo; Sabrina Margarucci; Umberto Galderisi; Stefania Crispi; Gianfranco Peluso
Journal:  Nutrients       Date:  2019-10-11       Impact factor: 5.717

4.  The effect of nanocurcumin on the incidence of atrial fibrillation, and markers of inflammation and oxidative stress level after coronary artery bypass graft surgery: A randomized, double-blind, placebo-controlled clinical study.

Authors:  Samira Hossaini Alhashemi; Amir Hooshang Mohammadpour; Reza Heidari; Mohammad Hossein Nikoo; Mohammad Hassan Nemati; Afsaneh Vazin
Journal:  Avicenna J Phytomed       Date:  2022 Sep-Oct

Review 5.  Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress.

Authors:  Jorge G Farías; Víctor M Molina; Rodrigo A Carrasco; Andrea B Zepeda; Elías Figueroa; Pablo Letelier; Rodrigo L Castillo
Journal:  Nutrients       Date:  2017-09-01       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.